Malaria drug has no benefit for Covid-19 patients, but higher death rate: study

Published
0

A malaria drug widely touted as a potential cure for Covid-19 showed no benefit against the disease over standard care — and was in fact associated with more deaths, the biggest study of its kind has revealed.

Researchers looked at the medical records of 368 veterans hospitalised in US who either died or were discharged by April 11.

Death rates for patients on hydroxychloroquine were 28 per cent, compared to 22pc when it was taken with the anti-biotic azithromycin — a combination favoured by French scientist Didier Raoult, whose study on the subject in March triggered a surge of global interest in the drug.

Read more here.

Opinion

Editorial

Yemen offensive
Updated 04 Oct, 2026

Yemen offensive

The best option, therefore, is for Muslim and Arab states to help restore the Saudi-Houthi ceasefire.
Growth transition
04 Oct, 2026

Growth transition

PRIME Minister Shehbaz Sharif’s recent call to move from stabilisation to growth, job creation and export ...
Protection at risk
04 Oct, 2026

Protection at risk

THE recent warning from UNHCR should alarm donor governments. Nearly 8.3m refugees and other forcibly displaced...
Talks, at last
Updated 03 Oct, 2026

Talks, at last

The government’s constant threats to suspend KP’s elected dispensation over a political protest have escalated hostilities considerably. In that context, both sides did well to start talking.
IWT’s future
Updated 03 Oct, 2026

IWT’s future

TOGETHER with the Kashmir dispute, India’s unilateral suspension of the Indus Waters Treaty has become the biggest...
Pained minds
03 Oct, 2026

Pained minds

IN Pakistan, mental healthcare is wedged between two extremes — a luxury or a stigma. Estimates cited by the...